Application of tilianin in preparation of medicine for improving expression of LXR-alpha

The invention discloses an application of tilianin in preparation of a medicine for improving expression of LXR-alpha, which belongs to the technical field of medicines, discloses a method for determining regulation and control of tilianin in LXR-alpha expression by taking H9c2 myocardial cell hypox...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DILINUER AILIAJI, ZHENG RUIFANG, DU YANWEN, XING JIANGUO, YU NING, REZIYAMU WUFUER
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses an application of tilianin in preparation of a medicine for improving expression of LXR-alpha, which belongs to the technical field of medicines, discloses a method for determining regulation and control of tilianin in LXR-alpha expression by taking H9c2 myocardial cell hypoxia/reoxygenation (H/R) injury as a model and taking LXR-alpha as a molecular target, and provides abasis for searching and developing medicines for effectively preventing and treating cardiovascular and cerebrovascular diseases. 本发明公开了田蓟苷在制备提高LXR-α的表达的药物中的应用，属于医药技术领域，以H9c2心肌细胞缺氧/复氧(H/R)损伤为模型，以LXR-α作为分子靶标，确定了田蓟苷在LXR-α表达中的调控，为寻找开发有效地防治心脑血管疾病的药物提供了依据。